Cinnamon may have therapeutic benefits on lipid profile, liver enzymes, insulin resistance, and high-sensitivity C-reactive protein in nonalcoholic fatty liver disease patients.

scientific article published on 6 December 2013

Cinnamon may have therapeutic benefits on lipid profile, liver enzymes, insulin resistance, and high-sensitivity C-reactive protein in nonalcoholic fatty liver disease patients. is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1016/J.NUTRES.2013.11.005
P698PubMed publication ID24461315
P5875ResearchGate publication ID259916145

P2093author name stringBahram Rashidkhani
Azita Hekmatdoost
Faezeh Askari
P2860cites workCinnamon extract improves fasting blood glucose and glycosylated hemoglobin level in Chinese patients with type 2 diabetes.Q51354665
P433issue2
P921main subjectliver diseaseQ929737
insulin resistanceQ1053470
metabolic dysfunction–associated steatotic liver diseaseQ1546498
fatty liver diseaseQ6058862
preproinsulinQ7240673
P304page(s)143-148
P577publication date2013-12-06
P1433published inNutrition ResearchQ15752977
P1476titleCinnamon may have therapeutic benefits on lipid profile, liver enzymes, insulin resistance, and high-sensitivity C-reactive protein in nonalcoholic fatty liver disease patients.
P478volume34

Reverse relations

cites work (P2860)
Q50441886Caffeine ameliorates high energy diet-induced hepatic steatosis: sirtuin 3 acts as a bridge in the lipid metabolism pathway.
Q34266920Cassia cinnamon does not change the insulin sensitivity or the liver enzymes in subjects with impaired glucose tolerance
Q96306078Cinnamon extract supplementation improves inflammation and oxidative stress induced by acrylamide: An experimental animal study
Q64929772Dietary and Pharmacological Treatment of Nonalcoholic Fatty Liver Disease.
Q26777658Dietary supplements and pediatric non-alcoholic fatty liver disease: Present and the future
Q47300971Effects of cinnamon supplementation on antioxidant status and serum lipids in women with polycystic ovary syndrome.
Q92413069Effects of cinnamon supplementation on expression of systemic inflammation factors, NF-kB and Sirtuin-1 (SIRT1) in type 2 diabetes: a randomized, double blind, and controlled clinical trial
Q38808524Effects of dietary polyphenols on metabolic syndrome features in humans: a systematic review
Q37748010Egg consumption and risk of non-alcoholic fatty liver disease
Q53625645Flaxseed supplementation in non-alcoholic fatty liver disease: a pilot randomized, open labeled, controlled study.
Q48102672Insulin resistance improvement by cinnamon powder in polycystic ovary syndrome: A randomized double-blind placebo controlled clinical trial
Q39180593Nonalcoholic Fatty Liver Disease, the Gut Microbiome, and Diet.
Q26796448Nonalcoholic steatohepatitis: emerging targeted therapies to optimize treatment options
Q93354367Optimization of green extraction methods for cinnamic acid and cinnamaldehyde from Cinnamon (Cinnamomum cassia) by response surface methodology
Q34993617Pleurotus ostreatus opposes mitochondrial dysfunction and oxidative stress in acetaminophen-induced hepato-renal injury
Q39311587Pomegranate juice prevents development of non-alcoholic fatty liver disease in rats by attenuating oxidative stress and inflammation
Q58753073Potential Therapeutic Benefits of Herbs and Supplements in Patients with NAFLD
Q35127037Recent advances in dietary supplementation, in treating non-alcoholic fatty liver disease.
Q26778020Relevant Aspects of Nutritional and Dietary Interventions in Non-Alcoholic Fatty Liver Disease
Q48043740The Effects of Onion Consumption on Prevention of Nonalcoholic Fatty Liver Disease
Q90893893The effects of curcumin supplementation on liver enzymes, lipid profile, glucose homeostasis, and hepatic steatosis and fibrosis in patients with non-alcoholic fatty liver disease
Q37119409The effects of onion consumption on treatment of metabolic, histologic, and inflammatory features of nonalcoholic fatty liver disease.
Q40669013The effects of resveratrol supplementation on cardiovascular risk factors in patients with non-alcoholic fatty liver disease: a randomised, double-blind, placebo-controlled study.
Q92759314The role of elevated alanine aminotransferase (ALT), FasL and atherogenic dyslipidemia in type II diabetes mellitus
Q93147070Therapeutic Mechanisms of Herbal Medicines Against Insulin Resistance: A Review
Q94150267Turmeric, Pepper, Cinnamon, and Saffron Consumption and Mortality

Search more.